Sebastian BioPharma
PrivateLast Round
Accelerator
Jun 1, 2025
Total Funding Raised
$8.53M
Company Overview
Sebastian BioPharma is a biotechnology company that develops tumor-targeted, multi-pathway therapeutics for immunotherapy-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sebastian BioPharma Comparables
Compare Sebastian BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tallac Therapeutics | 73% | |
| Gilead Sciences | 69% | |
| Replicate Bioscience | 67% |
Sebastian BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2025 |
Sebastian BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders Fund | Angel |
| SCbioDrive | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Received funding from SCbioDrive.
Sebastian BioPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sebastian BioPharma's valuation, stock price, and market status.
Is Sebastian BioPharma a public or private company?
Sebastian BioPharma is a private company.
What is the current stock price of Sebastian BioPharma?
Sebastian BioPharma is a private company with no public stock price. No recent secondary market data is available.
How much is Sebastian BioPharma worth (valuation)?
Valuation information for Sebastian BioPharma is not publicly available.
Can I buy Sebastian BioPharma stock?
Sebastian BioPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sebastian BioPharma's last funding round?
Sebastian BioPharma's most recent funding round was Accelerator on June 1, 2025.
Who are the main investors in Sebastian BioPharma?
Key investors in Sebastian BioPharma include Founders Fund, SCbioDrive.
Will Sebastian BioPharma IPO soon?
No public IPO plans have been announced for Sebastian BioPharma.
How can I track Sebastian BioPharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sebastian BioPharma's secondary market activity and sign up for updates.